Related references
Note: Only part of the references are listed.Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole
Imad Zalloum et al.
MOLECULAR BIOLOGY REPORTS (2012)
Metabolite characterization of a novel anti-cancer agent, icotinib, in humans through liquid chromatography/quadrupole time-of-flight tandem mass spectrometry
Dongyang Liu et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2011)
Cytochrome P450 2C19 Polymorphism is Associated with Reduced Clopidogrel Response in Cerebrovascular Disease
Jun-Beom Lee et al.
YONSEI MEDICAL JOURNAL (2011)
Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17
Alain Li-Wan-Po et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Effects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphism
Hui-Yan Shi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Pilot Study of the Antiplatelet Effect of Increased Clopidogrel Maintenance Dosing and Its Relationship to CYP2C19 Genotype in Patients With High On-Treatment Reactivity
Colin M. Barker et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2010)
Quantitative determination of icotinib in human plasma and urine using liquid chromatography coupled to tandem mass spectrometry
Dongyang Liu et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Investigation of the Influence of CYP1A2 and CYP2C19 Genetic Polymorphism on 2-Cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2-butenamide (A77 1726) Pharmacokinetics in Leflunomide-Treated Patients with Rheumatoid Arthritis
Petra Bohanec Grabar et al.
DRUG METABOLISM AND DISPOSITION (2009)
Increased omeprazole metabolism in carriers of the CYP2C19*17 allele;: a pharmacokinetic study in healthy volunteers
R. Michael Baldwin et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: Comparison with Korean, Chinese, and Caucasian populations
S. P. Myrand et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Clinical significance of the cytochrome P4502C19 genetic polymorphism
Z Desta et al.
CLINICAL PHARMACOKINETICS (2002)
Share Paper
